Difference between revisions of "Angiotensinamide"
From Self-sufficiency
m (Stub sorting and placement of stub template(s)) |
m (1 revision) |
(No difference)
|
Latest revision as of 15:39, 19 September 2010
File:Angiotensinamide.svg | |
Systematic (IUPAC) name | |
---|---|
2-[(1-{2-[2-(2-{2-[2-(2-amino-3-carbamoylpropanamido)-5-[(diaminomethylidene)amino]pentanamido]-3-methylbutanamido}-3-(4-hydroxyphenyl)propanamido)-3-methylbutanamido]-3-(1H-imidazol-5-yl)propanoyl}pyrrolidin-2-yl)formamido]-3-phenylpropanoic acid | |
Clinical data | |
Routes of administration | Intravenous infusion |
Identifiers | |
CAS Number | 53-73-6 |
ATC code | C01CX06 (WHO) |
PubChem | CID 5890 |
Chemical data | |
Formula | C49H70N14O11 |
Molar mass | 1031.17 g/mol[[Script error: No such module "String".]] |
(verify) |
Angiotensinamide (INN; BAN and USAN angiotensin amide) is a potent vasoconstrictor used as a cardiac stimulant. It is a derivative of angiotensin II.
See also
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Cardiac stimulants
- Cardiovascular system drug stubs
- 2Fix